REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
FAST-TRACK DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 10
Filing date
05/22/2019
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
LU
Examiner
SAITO, KIM
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "FAST-TRACK DIAGNOSTICS" in black with the wording "FAST-TRACK" appearing above the word "DIAGNOSTICS" with two red greater than symbols side by side to the left of the wording.
Holders and representatives
Holders
Fast-Track Diagnostics Luxembourg S.a.r.l.
Representatives
Marie Anne Mastrovito Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry; chemicals for use in science; chemical preparations for analytical and diagnostic purposes in laboratory use other than for medical or veterinary purposeschemical preparations for analytical and diagnostic purposesreagent kits comprising oligonucleotides and polynucleotidespolymerase and buffer for use in the biotechnology fields; proteins for immunoassay for medical research purposes in the field of detection of cancersbacteriafungiautoimmune diseaseinfectiongastrointestinal disorders and diseasesvirusessexually transmitted diseasesinfluenzaliver diseasesblood diseases and disorderscardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory disease and for toxicological studies for scientific use; chemical productsproteins for immunoassay for scientific and medical research; chemicalsproteins for analytical purposesdiagnostic purposes and medical research useother than for medical and veterinary use; laboratory testing chemicals and reagents for research purposes containing proteins and immunoassay reagents; chemicalsproteins for analytical purposesdiagnostic purposes for medical research use other than for medical and veterinary use; laboratory chemicalsantibody reagent used for the detection of antigens in cell and tissue and body fluid sample analysis for in vitro diagnostic use; laboratory chemicals for analytical purposes other than for medical and veterinary use; biological reagents for use in molecular biologyother than for medical and veterinary use; chemical test reagents for scientific and research use
Class 5
Diagnostic preparations for medical or veterinary purposes; pharmaceutical preparations for treatment of cancersbacterial infectionsfungal infectionsviral infectionsautoimmune diseasegastrointestinal disorders and diseasesvirusessexually transmitted diseasesinfluenzaliver diseasesblood diseases and disorderscardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory diseases; chemicals for medical purposesfor use in the treatment and prevention of treatment of cancersbacterial infectionsfungal infectionsviral infectionsautoimmune diseasegastrointestinal disorders and diseasesvirusessexually transmitted diseasesinfluenzaliver diseasesblood diseases and disorderscardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory diseases; diagnostic proteins for medical laboratory analysisprotein and nucleic acid arrays for diagnostic purposes used in medical laboratories; diagnostic reagents for medical and veterinary use; reagents for medical and veterinary use; chemical reagents for medical or veterinary purposes; chemical reagents for use in medicine
Class 10
Testinganalysis and diagnostic apparatus and instruments for medical diagnostic purposesPCR thermocyclerimmunoassay analyzersclinical chemistry analyzersmedical diagnostic instruments for analysis of body fluidsmedical instruments for analyzing and identifying bacteriaflow cytometers for medical diagnostic uses
Publications
History of USPTO decisions and trademark events.
49 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/24/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/04/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/01/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
07/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/13/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/27/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/09/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/23/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/19/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/15/2020
GNFR
FINAL REFUSAL E-MAILED
06/15/2020
CNFR
FINAL REFUSAL WRITTEN
06/15/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/19/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/19/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/19/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/13/2020
RFNT
REFUSAL PROCESSED BY IB
12/13/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/14/2019
RFRR
REFUSAL PROCESSED BY MPU
11/14/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/24/2019
CNRT
NON-FINAL ACTION WRITTEN
10/23/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/12/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/10/2019
DOCK
ASSIGNED TO EXAMINER
09/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
08/22/2019
Continuous trademark protection
Get notified about every new filing that threatens FAST-TRACK DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.